In chronic COVID-19, elevated levels of both IL-6 and adenosine have been observed, with IL-6 contributing to the proinflammatory ‘cytokine storm’ and adenosine being considered as a potential therapeutic for severe cases due to its anti-inflammatory effects [59]. The gene discussed is IL6; the disease is COVID-19.